The board of directors of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has received a resignation letter tendered by Mr. CHEN Yangui, an executive Director, resigning from his positions as an executive Director due to his decision to devote more time to his other business commitments. The resignation of Mr. Chen as an executive Director is subject to the approval and the election of a new Director to fill his casual vacancy by the Shareholders at an extraordinary general meeting of the Company to be convened and held (the ??EGM??).
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.84 HKD | +0.31% | +7.36% | +35.30% |
Apr. 09 | Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma | MT |
Apr. 01 | Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+35.30% | 1.44B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 1558 Stock
- News YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
- YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Announces Resignation of Chen Yangui as Executive Director